<< Go Back to Past Meetings

2017 Annual Scientific Meeting

September 16-19, 2017 | Dallas, Texas

PROGRAM
2016 ANNUAL SCIENTIFIC MEETING ONDEMAND
Watch all of the great educational content from the 21st Annual Scientific Meeting, anytime and anywhere! Annual Scientific Meeting OnDemand 2017 provides you complete access to the program, which includes basic science, translational and clinical science. For more information, click on the button below.

CONTINUING EDUCATION CREDIT
PHYSICIANS
The Heart Failure Society of America designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.75 MOC points in the Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
[_/su_spoiler]
PHARMACISTS

The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). Pharmacists may earn up to 20.50 hours of knowledge-based CPE. To earn credit, participants must use the 5-digit code provided at the end of each accredited presentation to access the online program evaluations posted on ipharmCE.UCDenver.edu. Once evaluations are completed, CPE will be uploaded to CPE monitor within 2 days.

Information for Pharmacists
Only the topics listed below are accredited for continuing pharmacy education. The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). Pharmacists may earn up to 20.50 hours of knowledge-based CPE. To earn credit, participants must use the 5-digit code provided at the end of each accredited presentation to access the online program evaluations posted on ipharmCE.UCDenver.edu. Once evaluations are completed, CPE will be uploaded to CPE monitor within 2 days.

Saturday 9/16, 10:30 AM - 12:00 PM
Current and Emerging Approaches to Diagnosis and Evaluation of HFpEF
ACPE# 0008-9999-17-112-L01-P
(1.5 contact hours - knowledge-based)

Saturday 9/16, 2:30 PM - 4:00 PM
Joint Session with AHA: What Can You Do to Prevent HF
ACPE# 0008-9999-17-113-L01-P
(1.5 contact hours - knowledge-based)

Sunday 9/17, 9:00 AM - 10:00 AM
Plenary
ACPE# 0008-9999-17-128-L01-P
(1 contact hours - knowledge-based)

Sunday 9/17, 10:30 AM - 12:00 PM
Hope on the Horizon: Pharmacotherapies in Development for HFpEF
ACPE# 0008-9999-17-114-L01-P
(1.5 contact hours - knowledge-based)

Sunday 9/17, 1:00 PM - 2:00 PM
How to Manage Diabetes in HF
ACPE# 0008-9999-17-115-L01-P
(1 contact hours - knowledge-based)

Sunday 9/17, 1:00 PM - 2:00 PM
Know When to Hold ’em: Drugs to Avoid or Use Cautiously in Heart Failure
ACPE# 0008-9999-17-116-L01-P
(1 contact hours - knowledge-based)

Sunday 9/17, 2:15 PM - 3:45 PM
Cardiac Transplantation 2017-Where Do We Stand
ACPE# 0008-9999-17-117-L01-P
(1.5 contact hours - knowledge-based)

Sunday 9/17, 4:15 PM - 5:45 PM
Pulmonary Comorbidities of HF - COPD and Sleep Apnea
ACPE# 0008-9999-17-118-L01-P
(1.5 contact hours - knowledge-based)

Monday 9/18, 8:30 AM - 10:00 AM
Clinical Conundrums: Case Discussions
ACPE# 0008-9999-17-119-L01-P
(1.5 contact hours - knowledge-based)

Monday 9/18, 10:30 AM - 12:00 PM
From Cancer Biology to Cardiovascular Pathophysiology
ACPE# 0008-9999-17-120-L01-P
(1.5 contact hours - knowledge-based)

Monday 9/18, 12:15 PM - 1:15 PM
How to Make the Most of Social Media for Physicians and Patients
ACPE# 0008-9999-17-121-L04-P
(1 contact hours - knowledge-based)

Monday 9/18, 1:30 PM - 3:00 PM
HFrEF Therapy in 2017 and Beyond: Sacubitril, Ivabradine, Patriomer and More
ACPE# 0008-9999-17-122-L01-P
(1.5 contact hours - knowledge-based)

Monday 9/18, 3:30 PM - 5:00 PM
Aging Hearts: Controversies and Opportunities for the Treatment of Heart Failure Among Older Adults
ACPE# 0008-9999-17-123-L01-P
(1.5 contact hours - knowledge-based)

Tuesday 9/19, 7:00 AM - 8:15 AM
Developing Heart Failure Syndromes – What do we know about HFrecEF?
ACPE# 0008-9999-17-124-L01-P
(1.25 contact hours - knowledge-based)

Tuesday 9/19, 8:30 AM - 10:00 AM
HF Care in 1987, 2017, 2047: How It Was, How It Is, and How It Will Be
ACPE# 0008-9999-17-125-L01-P
(1.5 contact hours - knowledge-based)

Tuesday 9/19, 8:30 AM - 10:00 AM
What's New with ARNIs
ACPE# 0008-9999-17-126-L01-P
(1.5 contact hours - knowledge-based)

Tuesday 9/19, 10:15 AM - 11:30 AM
Hyde Park
ACPE# 0008-9999-17-127-L04-P
(1.25 contact hours - knowledge-based)

[__/su_spoiler] [_/su_spoiler]
NURSES

This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 24.25 contact hours.
Approval through 09/12/2019; ONA #21084

Please call HFSA at 301-312-8635  for more information about contact hours. 

Satellite Symposia

Master Class on Heart Failure: Implementing Real-World Experience and New Advances to Reduce Hospitalizations and Costs
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 2 contact hours.
Approval through 09/12/2019; ONA # 21112

Cardiac Amyloidosis: Stop Missing It!  A Multi-Disciplinary Approach to a Not So Rare Disease
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 1.5 contact hours.
Approval through 09/12/2019; ONA #21105

Discussing the Impact of Hyperkalemia on Management Strategies for Patients with Heart Failure: A Town Hall Forum
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 1.0 contact hours.
Approval through 09/12/2019; ONA #21104

Applying Clinical Advances in HF Management to Optimize Patient Outcomes
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 1.5 contact hours.
Approval through 09/12/2019 ONA # 21116

“Smart” Therapy in Heart Failure: From Remote Monitoring to Assisted Circulation
This continuing nursing education activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This activity is approved for 2.0 contact hours.
Approval through 09/12/2019; ONA # 21120

Pharmacology Hours for Nurses

For Nurses who require pharmacology hours for their certification or licensure renewal, this year the HFSA Annual meeting offers opportunities to accrue these hours.

Here are some sessions offered:

Sunday, September 17, 2017
10:30 AM – 12:00 PM
Hope for HFpEF on the Horizon Pharmacotherapies in Development for HFpEF

Sunday, September 17, 2017
1:00 PM – 2:00 PM
How-to Session: Know When to Hold’em: Drugs to Avoid or Use Cautiously in HF

Sunday, September 17, 2017
4:15 PM – 5:45 PM
cGMP Drugs in HF: New Developments

Monday, September 18, 2017
1:30 PM - 3:00 PM
HFrEF Therapy in 2017 and Beyond: Sacubitril, Ivabradine, Patriomer and More

For those certified with ANCC and interested in obtaining pharmacology hour credits, 60 minutes of pharmacology content equal one contact hour.
Please keep the conference agenda pertaining to the pharmacology session and keep on file for future reference. This may be submitted and serve as evidence to validate the contact hour calculation. A narrative note describing pharmacology content within agenda may be necessary to validate content. Pharmacotherapeutic content does not need to be presented by a nurse for the hours to be eligible for re-certification; however, the presenter must have content expertise in pharmacology.

Further information is available at the ANCC website, www.nursecredentialing.org.

[__/su_spoiler] [_/su_spoiler]
CLAIMING CONTINUING EDUCATION CREDIT

To receive your CME credit, go to: http://ceu.experientevent.com/HFS171

Evaluations
An evaluation must be completed in order to receive a credit certificate for the scientific meeting or for satellite symposia. All evaluations will be electronic and will be formatted for smart phones, tablets and computers. They can also be accessed using the CE kiosks in the registration area.

Physicians & Nurses
Physician and nursing continuing education credit certificates for the scientific meeting and for satellite symposia can be requested on-site using smart phones, tablets, computers, or the CE kiosks in the registration area.

To make a request after the meeting, visit the following site: http://ceu.experientevent.com/HFS171

Certificates will be issued only to individuals registered for the Annual Scientific Meeting. If necessary, attendance will be verified based on information collected by hand-held scanners at meeting room entrances.

For more information regarding continuing education certification and credits, refer to your Program or visit the official meeting app for more details.

For Pharmacists
All CPE evaluations are accessed online at ipharmCE.UCDenver.edu.

Pharmacists will need to create a profile on iPharmCE to access evaluations and claim CPE credit.  If you don’t have an account already, create one by entering a valid email address under New Account Sign‐up, and following the on‐screen instructions.  Once logged in, click Complete Live Activity Post‐tests and Evaluations on the left side of the screen, scroll down to the group titled HFSA 2017, and select the presentation title.

CPE Credit for each presentation will be uploaded to CPE Monitor upon completion of the evaluation. General instructions on how to access the online evaluation platform will also be emailed to pharmacists who sign‐in after the program.

For more information, download the Pharmacist Continuing Education handout.

AWARDS
2017 HFSA Lifetime Achievement Award
Supported by Cytokinetics
Barry H. Greenberg, MD, FHFSA

View Barry H. Greenberg's Bio

Barry H. Greenberg, MD, is a Distinguished Professor of Medicine and Director of the Advanced Heart Failure Treatment Program at the University of California, San Diego (UCSD). He earned a medical degree from the State University of New York Upstate Medical University College of Medicine in Syracuse and completed his internship at George Washington University Hospital and residency in internal medicine at Yale-New Haven Hospital. Following research training at the Lipid Metabolism Branch of the National Heart, Lung, and Blood Institute in Bethesda, Maryland and the Cardiovascular Research Institute of the University of California, San Francisco (UCSF), he completed a fellowship in cardiology at UCSF. He then joined the faculty of Oregon Health Sciences University School of Medicine. Prior to arriving at UCSD, he was visiting professor in residence at the Royal Postgraduate Medical School in London, England and at the Laboratoire de Médicine Expérimentale of the Collège de France in Paris.

Dr. Greenberg’s clinical research focuses on understanding mechanisms of cardiac dysfunction and developing new heart failure therapies. In addition to investigator initiated research, he has served on the executive steering committees of numerous international multicenter heart failure trials. In addition, Dr. Greenberg directs a basic science laboratory that studies the molecular basis of cardiac remodeling, myocardial fibrosis and the development of novel therapies. He has published extensively in medical journals throughout his career.

Dr. Greenberg is co-editor of Congestive Heart Failure: Pathophysiology, Diagnosis, and Comprehensive Approach to Management, the first comprehensive text in this field, now in its 3rd edition and is editor of Myocardial Remodeling: Mechanisms and Treatment, published in 2006 and Management of Heart Failure published in 2010. He served as Associate Editor for the Journal of the American College of Cardiology from 2002-2014 and is a member of the editorial boards of several cardiology and subspecialty journals.

Dr. Greenberg is a founding member and past President of the Heart Failure Society of America (HFSA). He chaired the initial HFSA Heart Failure Board Review Course and he also has served as Chair for numerous HFSA Committees (including Education, Advocacy, Nominating, and Corporate Affairs) and for the Strategic Development initiative in 2010.

Dr. Greenberg is an active clinician and teacher. He has been recognized for many years as being one of the “Best Doctors in America” and “Best Doctors in San Diego.”

[_/su_spoiler]

For a complete list of past HFSA Lifetime Achievement Award winners, visit www.hfsa.org/awards

2017 HFSA Nursing Leadership Award
Supported by Cytokinetics
Barbara Riegel, PhD, RN, FAHA, FAAN

View Barbara Riegel's Bio

Dr. Barbara Riegel is the Edith Clemmer Steinbright Professor of Gerontology at the University of Pennsylvania, School of Nursing and Co-editor of the Journal of Cardiovascular Nursing.

Dr. Riegel’s significant contributions in heart failure (HF) research have systematically addressed the quality and effectiveness of HF management programs, nursing practice, and patient outcomes worldwide. As an internationally acclaimed nurse scientist, Dr. Reigel’s program of research focuses on outcome-based, theory-driven research on self-care of HF. For over 20 years, Dr Riegel has developed, tested and refined a theory of HF self-care that is used extensively nationally and internationally by many other Interprofessional scientists studying HF self-care. She also developed the Self-Care of Heart Failure Index (SCHFI), the first instrument to comprehensively measure self-care in patients with HF.  The SCHFI is considered the preeminent measure of self-care in HF, has been translated in 16 languages and used in more than 30 countries around the world demonstrating the global impact of Dr Riegel’s important work. Dr. Riegel’s research has culminated in hundreds of publications and presentations, and she has mentored over 100 students and nurse scientists worldwide.

Dr Riegel’s leadership in HF nursing is recognized through her service on numerous clinical guideline panels and as co-author on more than16 clinical guidelines that are widely cited and are extremely influential in standardizing care for individuals with HF including the 2013 ACCF/AHA Guideline for the Diagnosis and Treatment of Heart Failure. As a member of HFSA since 1997, Dr. Riegel’s has served in numerous ways including important leadership roles as the Co-Chair for the Program Committee, Chair of the Clinical Practice Award Committee, and Nursing Research Award Committee.

[_/su_spoiler]

For a complete list of past HFSA Nursing Leadership Award winners, visit www.hfsa.org/awards

2017 HFSA Clinical Excellence in Nursing Award
Johana Rocio Almansa, DNPc, RN, ANP-BC, CHFN

View Johana Rocio Almansa's Bio

Johana Rocio Almansa DNPc, R.N. ANP-BC CHFN immigrated from Colombia, South America at the age of 16 years old. While learning English as a second language, Ms. Almansa graduated with honors with an Associate Degree in Nursing in 1999.  After obtaining a Bachelors of Science in Nursing at Florida Atlantic University in 2004, Ms. Almansa joined the open-heart surgery team at Johns Hopkins Hospital, where she participated in the care of Left Ventricular Assist Device and Heart Transplant patients. During her six years working on the cardiac surgery team, Ms.  Almansa obtained certification as a Registered Nurse First Assistant, a Post Baccalaureate Certificate in Nursing Education and a Masters of Science in Nursing as an Adult/Gerontology Nurse Practitioner at the University of Maryland. More recently, Ms. Almansa in her role as nurse practitioner helped to start the Heart Failure Bridge Clinic at Johns Hopkins, where she developed an interest in Cardiac Amyloidosis (CAm). While the primary focus of the clinic is to facilitate the transition from the inpatient to the outpatient arenas after discharge, Ms. Almansa created a support group for patients with CAm, becoming part of the national Amyloidosis Support Group Association. Ms. Almansa is a Certified Heart Failure Nurse and currently serves on the Education committee for the American Association of Heart Failure Nurses, the Heart Failure Society of America and the Amyloidosis Foundation. In 2014, Ms. Almansa was awarded the Johns Hopkins Heart of Gold award. Ms. Almansa has also participated in several medical mission trips to Latin America with the Johns Hopkins Cardiac Surgery team as well as the Mision Internacional de Medicos Americanos [MIMA] Foundation.

[_/su_spoiler]

For a complete list of past HFSA Clinical Excellence in Nursing Award winners, visit www.hfsa.org/awards

Investigator Awards & Oral Presentations
HFSA offers three award competitions to be named at the Annual Scientific Meeting:

Jay N. Cohn Young Investigator Award – Basic Science
Winner: Michele Esposito, Boston, MA
Primary LV Unloading with a Trans-valvular Axial Flow Pump Limits the Development of Ischemic Heart Failure After Acute Myocardial Infarction

Runner up: Sadiya Khan, Chicago, IL
Identification of a Novel Familial Fibrotic Cardiomyopathy with a Loss-of-Function

Jay N. Cohn Young Investigator Award – Clinical/Integrative Physiology
Winner: Ryan Dolan, Chicago, IL
Cardiac MRI Derived Extracellular Volume Fraction Sensitive to Acute Cardiac Allograft Rejection

Runner up: Daniel Hodson, New Haven, CT
Urine Sodium Content is Highlight Variable in Hospitalized Acute Heart Failure Patients: Lasix Urine is Not Necessarily "Half-Normal Saline"

Nursing Investigator Award
Winner: Christine Haedtke
Symptom Burden of Advanced Heart Failure despite Optimal Treatment

Runner up: Karen Distelhorst
Factors Associated with Adherence to 14-Day Office Appointments after Heart Failure Discharge

2017 POSTERS & ABSTRACTS
2016 ANNUAL MEETING PROGRAM COMMITTEE

2017 Program Committee

2017 Program Committee Co-Chairs
James C. Fang, MD, FHFSA
Karol S. Harshaw-Ellis, MSN, DNP, FHFSA
Kenneth B. Margulies, MD, FHFSA
Robert L. Page II, PharmD, MSHP, FHFSA

2017 Program Committee Members
Allen S. Anderson, MD
Barry E. Bleske, PharmD
Meredith A. Brisco-Bacik, MD, MSCE
Grace Rita R. Domingo, MSN, DNP
G. Michael Felker, MD, FHFSA
Paul R. Forfia, MD
Michael M. Givertz, MD, FHFSA
Roger J. Hajjar, MD
Joshua M. Hare, MD
Eileen M. Hsich, MD
Daniel Jacoby, MD
Michelle M. Kittleson, MD, PhD
Robb D. Kociol, MD
Bonnie Ky, MD, MSCE
Eldrin F. Lewis, MD
Gregory Lewis, MD
Douglas L. Mann, MD, FHFSA
Colleen K. McIlvennan, DNP, ANP, FHFSA
Ana Morales, MS, LGC
Jose N. Nativi-Nicolau, MD
Tien M. H. Ng, PharmD, FHFSA
Sean P. Pinney, MD
Craig Selzman, MD
Nancy K. Sweitzer, MD, PhD
Ryan J. Tedford, MD
Brenda S. Thompson, MS, APRN, CNS, CCRN, FAHA
Christine M. Thompson, MS
Nir Uriel, MD
Orly Vardeny, PharmD, FHFSA
Jia-Rong Wu, PhD, RN, MSN
Payman Zamani, MD, FHFSA

2017 Board Liaison
Sean P. Collins, MD, MSc, FHFSA